These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 9096663

  • 1. Annamycin circumvents resistance mediated by the multidrug resistance-associated protein (MRP) in breast MCF-7 and small-cell lung UMCC-1 cancer cell lines selected for resistance to etoposide.
    Perez-Soler R, Neamati N, Zou Y, Schneider E, Doyle LA, Andreeff M, Priebe W, Ling YH.
    Int J Cancer; 1997 Mar 28; 71(1):35-41. PubMed ID: 9096663
    [Abstract] [Full Text] [Related]

  • 2. An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein.
    Doyle LA, Ross DD, Ordonez JV, Yang W, Gao Y, Tong Y, Belani CP, Gutheil JC.
    Br J Cancer; 1995 Sep 28; 72(3):535-42. PubMed ID: 7669558
    [Abstract] [Full Text] [Related]

  • 3. Cellular pharmacology of the partially non-cross-resistant anthracycline annamycin entrapped in liposomes in KB and KB-V1 cells.
    Perez-Soler R, Ling YH, Zou Y, Priebe W.
    Cancer Chemother Pharmacol; 1994 Sep 28; 34(2):109-18. PubMed ID: 8194162
    [Abstract] [Full Text] [Related]

  • 4. The novel anthracycline annamycin is not affected by P-glycoprotein-related multidrug resistance: comparison with idarubicin and doxorubicin in HL-60 leukemia cell lines.
    Consoli U, Priebe W, Ling YH, Mahadevia R, Griffin M, Zhao S, Perez-Soler R, Andreeff M.
    Blood; 1996 Jul 15; 88(2):633-44. PubMed ID: 8695811
    [Abstract] [Full Text] [Related]

  • 5. Effect of β-elemene on the kinetics of intracellular transport of d-luciferin potassium salt (ABC substrate) in doxorubicin-resistant breast cancer cells and the associated molecular mechanism.
    Tang CY, Zhu LX, Yu JD, Chen Z, Gu MC, Mu CF, Liu Q, Xiong Y.
    Eur J Pharm Sci; 2018 Jul 30; 120():20-29. PubMed ID: 29704644
    [Abstract] [Full Text] [Related]

  • 6. Antitumor activity of free and liposome-entrapped annamycin, a lipophilic anthracycline antibiotic with non-cross-resistance properties.
    Zou Y, Ling YH, Van NT, Priebe W, Perez-Soler R.
    Cancer Res; 1994 Mar 15; 54(6):1479-84. PubMed ID: 8137251
    [Abstract] [Full Text] [Related]

  • 7. Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells.
    Marbeuf-Gueye C, Broxterman HJ, Dubru F, Priebe W, Garnier-Suillerot A.
    Mol Pharmacol; 1998 Jan 15; 53(1):141-7. PubMed ID: 9443942
    [Abstract] [Full Text] [Related]

  • 8. Multifactorial involvement of multidrug resistance-associated [correction of resistance] protein, DNA topoisomerase II and glutathione/glutathione-S-transferase in nonP-glycoprotein-mediated multidrug resistance in human bladder cancer cells.
    Kim WJ, Kakehi Y, Yoshida O.
    Int J Urol; 1997 Nov 15; 4(6):583-90. PubMed ID: 9477189
    [Abstract] [Full Text] [Related]

  • 9. Partial circumvention of multi-drug resistance by annamycin is associated with comparable inhibition of DNA synthesis in the nuclear matrix of sensitive and resistant cells.
    Ling YH, Zou Y, Priebe W, Perez-Soler R.
    Int J Cancer; 1995 May 04; 61(3):402-8. PubMed ID: 7729954
    [Abstract] [Full Text] [Related]

  • 10. Regulation of cellular glutathione modulates nuclear accumulation of daunorubicin in human MCF7 cells overexpressing multidrug resistance associated protein.
    Benderra Z, Trussardi A, Morjani H, Villa AM, Doglia SM, Manfait M.
    Eur J Cancer; 2000 Feb 04; 36(3):428-34. PubMed ID: 10708946
    [Abstract] [Full Text] [Related]

  • 11. MRP is frequently expressed in human lung-cancer cell lines, in non-small-cell lung cancer and in normal lungs.
    Giaccone G, van Ark-Otte J, Rubio GJ, Gazdar AF, Broxterman HJ, Dingemans AM, Flens MJ, Scheper RJ, Pinedo HM.
    Int J Cancer; 1996 Jun 11; 66(6):760-7. PubMed ID: 8647646
    [Abstract] [Full Text] [Related]

  • 12. Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression.
    Lee JS, Scala S, Matsumoto Y, Dickstein B, Robey R, Zhan Z, Altenberg G, Bates SE.
    J Cell Biochem; 1997 Jun 15; 65(4):513-26. PubMed ID: 9178101
    [Abstract] [Full Text] [Related]

  • 13. Possible role of the multidrug resistance-associated protein (MRP) in chemoresistance of human melanoma cells.
    Berger W, Hauptmann E, Elbling L, Vetterlein M, Kokoschka EM, Micksche M.
    Int J Cancer; 1997 Mar 28; 71(1):108-15. PubMed ID: 9096673
    [Abstract] [Full Text] [Related]

  • 14. Resistant mechanisms of anthracyclines--pirarubicin might partly break through the P-glycoprotein-mediated drug-resistance of human breast cancer tissues.
    Kubota T, Furukawa T, Tanino H, Suto A, Otan Y, Watanabe M, Ikeda T, Kitajima M.
    Breast Cancer; 2001 Mar 28; 8(4):333-8. PubMed ID: 11791127
    [Abstract] [Full Text] [Related]

  • 15. MRP- and BCL-2-mediated drug resistance in human SCLC: effects of apoptotic sphingolipids in vitro.
    Khodadadian M, Leroux ME, Auzenne E, Ghosh SC, Farquhar D, Evans R, Spohn W, Zou Y, Klostergaard J.
    Lung Cancer; 2009 Oct 28; 66(1):48-57. PubMed ID: 19195736
    [Abstract] [Full Text] [Related]

  • 16. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance.
    Schneider E, Horton JK, Yang CH, Nakagawa M, Cowan KH.
    Cancer Res; 1994 Jan 01; 54(1):152-8. PubMed ID: 7903202
    [Abstract] [Full Text] [Related]

  • 17. Decreased drug accumulation without increased drug efflux in a novel MRP-overexpressing multidrug-resistant cell line.
    Gaj CL, Anyanwutaku I, Chang YH, Cheng YC.
    Biochem Pharmacol; 1998 Apr 15; 55(8):1199-211. PubMed ID: 9719474
    [Abstract] [Full Text] [Related]

  • 18. ATP-dependent activity and mitochondrial localization of drug efflux pumps in doxorubicin-resistant breast cancer cells.
    Dartier J, Lemaitre E, Chourpa I, Goupille C, Servais S, Chevalier S, Mahéo K, Dumas JF.
    Biochim Biophys Acta Gen Subj; 2017 May 15; 1861(5 Pt A):1075-1084. PubMed ID: 28214549
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Modulation of doxorubicin cytotoxicity by ethacrynic acid.
    Awasthi S, Singhal SS, He N, Chaubey M, Zimniak P, Srivastava SK, Singh SV, Awasthi YC.
    Int J Cancer; 1996 Nov 04; 68(3):333-9. PubMed ID: 8903475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.